These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 35761204)

  • 1. Methylene blue for vasodilatory shock in the intensive care unit: a retrospective, observational study.
    Naoum EE; Dalia AA; Roberts RJ; Devine LT; Ortoleva J
    BMC Anesthesiol; 2022 Jun; 22(1):199. PubMed ID: 35761204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylene Blue for Vasoplegia During Extracorporeal Membrane Oxygenation Support.
    Ortoleva J; Roberts RJ; Devine LT; French A; Kawabori M; Chen F; Shelton K; Dalia AA
    J Cardiothorac Vasc Anesth; 2021 Sep; 35(9):2694-2699. PubMed ID: 33455885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylene blue administration in patients with refractory distributive shock - a retrospective study.
    Porizka M; Kopecky P; Dvorakova H; Kunstyr J; Lips M; Michalek P; Balik M
    Sci Rep; 2020 Feb; 10(1):1828. PubMed ID: 32020043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Story of Nitric Oxide, Sepsis and Methylene Blue: A Comprehensive Pathophysiologic Review.
    Saha BK; Burns SL
    Am J Med Sci; 2020 Oct; 360(4):329-337. PubMed ID: 32631574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement in Hemodynamics After Methylene Blue Administration in Drug-Induced Vasodilatory Shock: A Case Report.
    Laes JR; Williams DM; Cole JB
    J Med Toxicol; 2015 Dec; 11(4):460-3. PubMed ID: 26310944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylene Blue Administration for Distributive Shock States in Critically Ill Children.
    Bitterman Y; Hubara E; Hadash A; Ben-Ari J; Annich G; Eytan D
    Isr Med Assoc J; 2020 Jul; 22(7):404-408. PubMed ID: 33236563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of midodrine and methylene blue as catecholamine-sparing agents in intensive care unit patients with shock.
    Tchen S; Sullivan JB
    J Crit Care; 2020 Jun; 57():148-156. PubMed ID: 32145658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of methylene blue in patients with vasodilatory shock: A systematic review and meta-analysis.
    Zhao CC; Zhai YJ; Hu ZJ; Huo Y; Li ZQ; Zhu GJ
    Front Med (Lausanne); 2022; 9():950596. PubMed ID: 36237547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early adjunctive methylene blue in patients with septic shock: a randomized controlled trial.
    Ibarra-Estrada M; Kattan E; Aguilera-González P; Sandoval-Plascencia L; Rico-Jauregui U; Gómez-Partida CA; Ortiz-Macías IX; López-Pulgarín JA; Chávez-Peña Q; Mijangos-Méndez JC; Aguirre-Avalos G; Hernández G
    Crit Care; 2023 Mar; 27(1):110. PubMed ID: 36915146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylene blue versus vasopressin analog for refractory septic shock in the preterm neonate: A randomized controlled trial.
    Ismail R; Awad H; Allam R; Youssef O; Ibrahim M; Shehata B
    J Neonatal Perinatal Med; 2022; 15(2):265-273. PubMed ID: 34719443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of methylene blue on hemodynamic parameters and cytokine levels in refractory septic shock.
    Park BK; Shim TS; Lim CM; Lee SD; Kim WS; Kim DS; Kim WD; Koh Y
    Korean J Intern Med; 2005 Jun; 20(2):123-8. PubMed ID: 16134766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of methylene blue in addition to norepinephrine on the intestinal microcirculation in experimental septic shock.
    Nantais J; Dumbarton TC; Farah N; Maxan A; Zhou J; Minor S; Lehmann C
    Clin Hemorheol Microcirc; 2014; 58(1):97-105. PubMed ID: 25227191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catecholamine Vasopressor Support Sparing Strategies in Vasodilatory Shock.
    Buckley MS; Barletta JF; Smithburger PL; Radosevich JJ; Kane-Gill SL
    Pharmacotherapy; 2019 Mar; 39(3):382-398. PubMed ID: 30506565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxocobalamin for Vasodilatory Hypotension in Shock: A Systematic Review With Meta-Analysis for Comparison to Methylene Blue.
    Brokmeier HM; Seelhammer TG; Nei SD; Gerberi DJ; Mara KC; Wittwer ED; Wieruszewski PM
    J Cardiothorac Vasc Anesth; 2023 Sep; 37(9):1757-1772. PubMed ID: 37147207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylene Blue: Magic Bullet for Vasoplegia?
    Hosseinian L; Weiner M; Levin MA; Fischer GW
    Anesth Analg; 2016 Jan; 122(1):194-201. PubMed ID: 26678471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of methylene blue in an experimental model of calcium channel blocker-induced shock.
    Jang DH; Donovan S; Nelson LS; Bania TC; Hoffman RS; Chu J
    Ann Emerg Med; 2015 Apr; 65(4):410-5. PubMed ID: 25441767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Methylene Blue Dosing With Hemodynamic Response for the Treatment of Vasoplegia.
    Hohlfelder B; Douglas A; Wang L; Wanek M; Bauer SR
    J Cardiothorac Vasc Anesth; 2022 Sep; 36(9):3543-3550. PubMed ID: 35697643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic analysis of methylene blue for drug-induced shock.
    Warrick BJ; Tataru AP; Smolinske S
    Clin Toxicol (Phila); 2016 Aug; 54(7):547-55. PubMed ID: 27196698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasodilation in patients with calcium channel blocker poisoning treated with high-dose insulin: a comparison of amlodipine versus non-dihydropyridines.
    Cole JB; Lee SC; Prekker ME; Kunzler NM; Considine KA; Driver BE; Puskarich MA; Olives TD
    Clin Toxicol (Phila); 2022 Nov; 60(11):1205-1213. PubMed ID: 36282196
    [No Abstract]   [Full Text] [Related]  

  • 20. [Methylene blue in the treatment of vasodilatory shock: a Meta-analysis].
    Zhang X; Gao Y; Pan P; Wang Y; Li W; Yu X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Nov; 29(11):982-987. PubMed ID: 29151412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.